IPSEN (OTCMKTS:IPSEY) Shares Gap Up – Here’s What Happened
by Kim Johansen · The Markets DailyIPSEN (OTCMKTS:IPSEY – Get Free Report)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $46.30, but opened at $48.54. IPSEN shares last traded at $48.54, with a volume of 1,217 shares trading hands.
Analysts Set New Price Targets
Several analysts have issued reports on IPSEY shares. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of IPSEN in a research note on Tuesday, February 17th. UBS Group lowered shares of IPSEN from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 8th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.
Read Our Latest Report on IPSEY
IPSEN Price Performance
The firm has a fifty day simple moving average of $44.26 and a two-hundred day simple moving average of $38.55.
About IPSEN
Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.
The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).